Corneal immune privilege

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

This year marks the 100th anniversary of the first successful corneal transplant on a human subject. Corneal allografts enjoy an exceptionally high acceptance, with rejection occurring in less than 10% of the patients who have not previously received a corneal transplant and who do not have underlying ocular inflammation. Corneal grafts survive even though HLA typing and systemic immunosuppressive drugs are not employed. The remarkable success of corneal transplants is due to a combination of anatomical, physiological, and immunological properties that conspire to prevent the induction and expression of potentially destructive immune responses to the foreign transplant.

Original languageEnglish (US)
Pages (from-to)S158-S160
JournalOcular Surface
Volume3
Issue number4
StatePublished - Oct 1 2005

Fingerprint

Transplants
Histocompatibility Testing
Anniversaries and Special Events
Immunosuppressive Agents
Allografts
Inflammation
Pharmaceutical Preparations

Keywords

  • Corneal transplantation
  • Graft rejection
  • Immune privilege
  • Keratoplasty

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Corneal immune privilege. / Niederkorn, Jerry Y.

In: Ocular Surface, Vol. 3, No. 4, 01.10.2005, p. S158-S160.

Research output: Contribution to journalArticle

Niederkorn, JY 2005, 'Corneal immune privilege', Ocular Surface, vol. 3, no. 4, pp. S158-S160.
Niederkorn, Jerry Y. / Corneal immune privilege. In: Ocular Surface. 2005 ; Vol. 3, No. 4. pp. S158-S160.
@article{61ef3e93d6ef40389816c797859d5ba4,
title = "Corneal immune privilege",
abstract = "This year marks the 100th anniversary of the first successful corneal transplant on a human subject. Corneal allografts enjoy an exceptionally high acceptance, with rejection occurring in less than 10{\%} of the patients who have not previously received a corneal transplant and who do not have underlying ocular inflammation. Corneal grafts survive even though HLA typing and systemic immunosuppressive drugs are not employed. The remarkable success of corneal transplants is due to a combination of anatomical, physiological, and immunological properties that conspire to prevent the induction and expression of potentially destructive immune responses to the foreign transplant.",
keywords = "Corneal transplantation, Graft rejection, Immune privilege, Keratoplasty",
author = "Niederkorn, {Jerry Y.}",
year = "2005",
month = "10",
day = "1",
language = "English (US)",
volume = "3",
pages = "S158--S160",
journal = "Ocular Surface",
issn = "1542-0124",
publisher = "Ethis Communications, Inc.",
number = "4",

}

TY - JOUR

T1 - Corneal immune privilege

AU - Niederkorn, Jerry Y.

PY - 2005/10/1

Y1 - 2005/10/1

N2 - This year marks the 100th anniversary of the first successful corneal transplant on a human subject. Corneal allografts enjoy an exceptionally high acceptance, with rejection occurring in less than 10% of the patients who have not previously received a corneal transplant and who do not have underlying ocular inflammation. Corneal grafts survive even though HLA typing and systemic immunosuppressive drugs are not employed. The remarkable success of corneal transplants is due to a combination of anatomical, physiological, and immunological properties that conspire to prevent the induction and expression of potentially destructive immune responses to the foreign transplant.

AB - This year marks the 100th anniversary of the first successful corneal transplant on a human subject. Corneal allografts enjoy an exceptionally high acceptance, with rejection occurring in less than 10% of the patients who have not previously received a corneal transplant and who do not have underlying ocular inflammation. Corneal grafts survive even though HLA typing and systemic immunosuppressive drugs are not employed. The remarkable success of corneal transplants is due to a combination of anatomical, physiological, and immunological properties that conspire to prevent the induction and expression of potentially destructive immune responses to the foreign transplant.

KW - Corneal transplantation

KW - Graft rejection

KW - Immune privilege

KW - Keratoplasty

UR - http://www.scopus.com/inward/record.url?scp=84949119194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949119194&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - S158-S160

JO - Ocular Surface

JF - Ocular Surface

SN - 1542-0124

IS - 4

ER -